Principal Financial Group Inc Amphastar Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

A detailed history of Principal Financial Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 207,978 shares of AMPH stock, worth $5.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,978

Holding current value

$5.99 Million

% of portfolio

0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$36.84 - $53.4 $7.66 Million - $11.1 Million	207,978 New	207,978 $7.72 Million
Q3 2024 Oct 31, 2024	SELL	$36.99 - $50.09 $597,573 - $809,203	-16,155 Reduced 7.4%	202,017 $9.8 Million
Q2 2024 Jul 29, 2024	SELL	$38.65 - $43.48 $15,537 - $17,478	-402 Reduced 0.18%	218,172 $8.73 Million
Q1 2024 Apr 29, 2024	BUY	$42.85 - $63.45 $669,359 - $991,152	15,621 Added 7.7%	218,574 $9.6 Million
Q4 2023 Feb 07, 2024	SELL	$44.49 - $62.93 $315,122 - $445,733	-7,083 Reduced 3.37%	202,953 $12.6 Million
Q3 2023 Nov 02, 2023	SELL	$45.51 - $65.0 $852,083 - $1.22 Million	-18,723 Reduced 8.18%	210,036 $9.66 Million
Q2 2023 Aug 07, 2023	SELL	$35.77 - $58.38 $142,400 - $232,410	-3,981 Reduced 1.71%	228,759 $13.1 Million
Q1 2023 May 09, 2023	SELL	$27.99 - $37.92 $173,873 - $235,559	-6,212 Reduced 2.6%	232,740 $8.73 Million
Q4 2022 Feb 09, 2023	SELL	$27.93 - $31.27 $161,742 - $181,084	-5,791 Reduced 2.37%	238,952 $6.7 Million
Q3 2022 Nov 09, 2022	SELL	$27.56 - $37.75 $325,235 - $445,487	-11,801 Reduced 4.6%	244,743 $6.88 Million
Q2 2022 Aug 10, 2022	SELL	$29.79 - $42.29 $308,624 - $438,124	-10,360 Reduced 3.88%	256,544 $8.93 Million
Q1 2022 May 09, 2022	SELL	$22.96 - $36.45 $322,266 - $511,612	-14,036 Reduced 5.0%	266,904 $9.58 Million
Q4 2021 Feb 09, 2022	BUY	$18.14 - $23.29 $521,924 - $670,099	28,772 Added 11.41%	280,940 $6.54 Million
Q3 2021 Nov 09, 2021	SELL	$17.83 - $21.49 $27,030 - $32,578	-1,516 Reduced 0.6%	252,168 $4.79 Million
Q2 2021 Aug 10, 2021	BUY	$17.11 - $20.92 $39,010 - $47,697	2,280 Added 0.91%	253,684 $5.11 Million
Q1 2021 May 10, 2021	SELL	$17.21 - $20.65 $3,855 - $4,625	-224 Reduced 0.09%	251,404 $4.61 Million
Q4 2020 Feb 08, 2021	SELL	$17.76 - $21.24 $175,983 - $210,467	-9,909 Reduced 3.79%	251,628 $5.06 Million
Q3 2020 Nov 06, 2020	BUY	$17.99 - $22.22 $173,585 - $214,400	9,649 Added 3.83%	261,537 $4.9 Million
Q2 2020 Aug 05, 2020	SELL	$14.25 - $22.46 $115,054 - $181,342	-8,074 Reduced 3.11%	251,888 $5.66 Million
Q1 2020 May 12, 2020	SELL	$12.66 - $20.08 $136,120 - $215,900	-10,752 Reduced 3.97%	259,962 $3.86 Million
Q4 2019 Feb 05, 2020	SELL	$17.07 - $20.64 $195,707 - $236,637	-11,465 Reduced 4.06%	270,714 $5.22 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $22.62 $200,721 - $237,464	-10,498 Reduced 3.59%	282,179 $5.6 Million
Q2 2019 Aug 12, 2019	BUY	$18.92 - $22.96 $280,962 - $340,956	14,850 Added 5.35%	292,677 $6.18 Million
Q1 2019 May 10, 2019	SELL	$19.46 - $25.28 $55,713 - $72,376	-2,863 Reduced 1.02%	277,827 $5.68 Million
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $10,189 - $12,943	575 Added 0.21%	280,690 $5.59 Million
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $7,510 - $9,457	488 Added 0.17%	280,115 $5.39 Million
Q2 2018 Aug 13, 2018	BUY	$14.63 - $19.6 $90,691 - $121,500	6,199 Added 2.27%	279,627 $0
Q1 2018 May 14, 2018	BUY	$17.23 - $20.35 $99,744 - $117,806	5,789 Added 2.16%	273,428 $5.13 Million
Q4 2017 Feb 13, 2018	SELL	$17.76 - $19.75 $225,356 - $250,607	-12,689 Reduced 4.53%	267,639 $5.15 Million
Q3 2017 Nov 02, 2017	BUY	$14.73 - $17.99 $4.13 Million - $5.04 Million	280,328	280,328 $5.01 Million

Others Institutions Holding AMPH

# of Institutions

275

Shares Held

35.2M

Call Options Held

26.5K

Put Options Held

7.9K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.41B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Amphastar Pharmaceuticals, Inc. Transaction History